NCT03799783View on ClinicalTrials.gov

The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

September 28, 2019

Conditions
Procedural SedationBehavior Disorders
Interventions
DRUG

dexmedetomidine

To administer dexmedetomidine IV 2 μg/kg in 10 minutes (loading dose) followed by continuous infusion at a rate of 1 μg/kg/h until procedure was complete

Trial Locations (1)

Unknown

Pediatric Intensive Care Unit - Department of Woman's and Child's Health - Azienda Ospedaliera di Padova, Padua

All Listed Sponsors
lead

Azienda Ospedaliera di Padova

OTHER

NCT03799783 - The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders | Biotech Hunter | Biotech Hunter